Home/ Stocks/ PEN

Penumbra, Inc.

PEN XNYS

$322.23 -2.42 (-0.75%) ▼ 15-min delayed

Open

$324.91

High

$324.91

Low

$321.79

Volume

350.1K

Market Cap

$12.67B

About Penumbra, Inc.

Penumbra Inc is a thrombectomy company focused on developing technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. Its portfolio includes Computer-Assisted Vacuum Thrombectomy (CAVT), which is designed to remove blood clots throughout the body. The company offers products such as the Artemis Neuro Evacuation Device (used for surgical removal of fluid and tissue from the ventricles and cerebrum), Indigo System, Penumbra System Reperfusion Catheter, LANTERN Delivery Microcatheter, Penumbra Smart Coil, and ACE Reperfusion Catheters, among others. The company generates maximum revenue from the sale of its products in the United States, followed by international markets.

Sector: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS Employees: 4.7K Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$374.76M	$32.58M	$0.83
FY 2025	$1.40B	$177.69M	$4.57
Q3 2025	$354.69M	$45.85M	$1.17
Q2 2025	$339.45M	$45.27M	$1.17

Related Market News

No specific coverage for PEN yet. Check out our latest market news or earnings calendar.

Get PEN Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Penumbra, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.